PERCEPTIVE ADVISORS LLC

Holdings History for Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX)

Symbol: PRAX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 1,995,986 shares
Security Ownership %: 7.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Perceptive Advisors LLC ownership in Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share (PRAX)

17 Feb 2026 - Perceptive Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,995,986 shares of Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share (PRAX). This represents 7.2% ownership of the company. In their previous filing dated 22 Jul 2025, PERCEPTIVE ADVISORS LLC had reported owning 1,362,503 shares, indicating an increase of +46%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Perceptive Advisors LLC	7.2%	+7.3%	$575,742,162	1,995,986	+633,483	+46%	$288.45	13G/A	31 Dec 2025	17 Feb 2026, 16:00
Perceptive Advisors LLC	6.7%	+38%	$57,294,886	1,362,503	+381,609	+39%	$42.05	13G	15 Jul 2025	22 Jul 2025, 09:58
Perceptive Advisors LLC	4.8%	-47%	$36,489,257	980,894	-848,841	-46%	$37.20	13G/A	31 Mar 2025	15 May 2025, 16:30
Perceptive Advisors LLC	9.5%		$68,066,142	1,829,735			$37.20	13G/A	31 Dec 2024	14 Feb 2025, 16:15

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		11%	+2.3%	$588,296,914	1,995,986	+431,432	+28%	$294.74	Q4 2025
30 Sep 2025		2.4%	+1.3%	$82,921,362	1,564,554	+811,633	+108%	$53.00	Q3 2025
30 Jun 2025		1.2%	-0.36%	$31,660,328	752,921	-227,973	-23%	$42.05	Q2 2025
31 Mar 2025		1.3%	-0.47%	$37,146,456	980,894	-348,841	-26%	$37.87	Q1 2025
31 Mar 2025	call		-98%	$0	0	-500,000	-100%	$303.34	Q1 2025
31 Dec 2024		2.9%	+0.36%	$102,336,406	1,329,735	+165,700	+14%	$76.96	Q4 2024
31 Dec 2024	call	98%	+98%	$38,480,000	500,000	+500,000	NEW	$76.96	Q4 2024
30 Sep 2024		1.4%	+0.51%	$66,978,574	1,164,035	+413,805	+55%	$57.54	Q3 2024
30 Jun 2024		0.75%	-0.05%	$31,029,513	750,230	-71,359	-8.7%	$41.36	Q2 2024
31 Mar 2024		0.88%	+1.1%	$50,133,361	821,589	+821,589	NEW	$61.02	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.